MedTrace Logo

Southeast Netherlands Advanced Metastatic Breast Cancer Registry

NCT03577197 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2024-07-23

No results posted yet for this study

Summary

The Southeast Netherlands Advanced Breast Cancer (SONABRE) Registry is a real life multi-center study. The registry aims to include all patients diagnosed with advanced breast cancer as of 2007 in 11 hospitals in the Netherlands. Data on patient, tumor and treatment characteristics are collected retrospectively from electronic medical files by trained registry clerks.

Conditions

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • Pfizer

    collaborator INDUSTRY

  • Roche Pharma AG

    collaborator INDUSTRY

  • Eli Lilly and Company

    collaborator INDUSTRY

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Eisai Inc.

    collaborator INDUSTRY

  • Daiichi Sankyo

    collaborator INDUSTRY

  • AstraZeneca

    collaborator INDUSTRY

  • Gilead Sciences

    collaborator INDUSTRY

  • Academisch Ziekenhuis Maastricht

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577197 on ClinicalTrials.gov